GENPREX, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 8th, 2017 • Genprex, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 8th, 2017 Company Industry JurisdictionGenprex, Inc., a corporation organized and existing under the laws of State of Delaware (the “Company”), proposes to issue and sell to the purchasers, pursuant to the terms and conditions of this Underwriting Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreement”) entered into with the purchasers identified therein (each a “Purchaser” and collectively, the “Purchasers”), a minimum amount (the “Minimum Amount”) of shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company up to a maximum amount (the “Maximum Amount”) of shares of Common Stock (the “Securities”) pursuant to a Registration Statement on Form S-1 declared effective by the United States Securities and Exchange Commission (the “Commission”). The Company hereby confirms its agreement with Network 1 Financial Securities, Inc. (“Network 1” or the “Underwriter”) concerning the purchase and sale of the Securities as follows:
INDEMNITY AGREEMENTIndemnification Agreement • September 8th, 2017 • Genprex, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 8th, 2017 Company Industry JurisdictionTHIS INDEMNITY AGREEMENT (this “Agreement”) dated as of , 20 , is made by and between Genprex, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 8th, 2017 • Genprex, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledSeptember 8th, 2017 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into between Genprex, Inc. (“Company”) and Ryan Confer (“Employee”). This Agreement is effective as of the effective date provided below (“Effective Date”)
ESCROW DEPOSIT AGREEMENTEscrow Deposit Agreement • September 8th, 2017 • Genprex, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 8th, 2017 Company Industry JurisdictionThis ESCROW DEPOSIT AGREEMENT (this “Agreement”) dated as of this [ ] day of [ ] 2017, by and among GENPREX, INC., a Delaware corporation (the “Company”), having an address at 100 Congress Avenue, Suite 2000, Austin, Texas 78701, NETWORK 1 FINANCIAL SECURITIES, INC., a New Jersey corporation (the “Underwriter”), having an address at The Galleria, Penthouse, 2 Bridge Avenue, Building 2, Red Bank, NJ 07701, and SIGNATURE BANK (the “Escrow Agent”), a New York State chartered bank, having an office at 565 Fifth Avenue, 12th Floor, New York, New York 10017. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Preliminary Prospectus, dated September 8, 2017, of the Company, including all attachments, schedules and exhibits thereto (the “Prospectus”) included in Registration Statement on Form S-1 (File No. 333-219386).